Compression Therapy Market Size, Share, Demand, Segments and Forecast 2021-2027

The global compression therapy market size is projected to reach USD 4.51 billion by 2026, exhibiting a CAGR of 5.2% during the forecast period. Rising prevalence of cancer will be a key growth driver for this market in the coming decade, finds Fortune Business Insights™ in its report, titled “Compression Therapy Market Size, Share and Industry Analysis By Product (Compression Garments {Compression Bandages, Compression Stockings, and Others}, Compression Pumps, and Others), By Application (Venous Leg Ulcer, Deep Vein Thrombosis (DVT), Lymphedema, and Others), By End User (Hospitals & Clinics, Nursing Care Centers, Home Care, and Others), and Regional Forecast, 2019-2026”. The global disease burden of cancer, according to the International Agency for Research on Cancer (IARC), rose by an estimated 18.1 million new cases in 2018.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/compression-therapy-market-102689

List of Top Players Covered in the Report:

Tactile Systems Technology, Inc.
Smith & Nephew
medi GmbH & Co. KG
Arjo
SIGVARIS
Bio Compression Systems, Inc.
EssityAktiebolag (publ)
PAUL HARTMANN Pty. Ltd
3M
Cancer therapy, especially for breast and prostate cancers, generally involves dissection of lymph nodes, which causes disruption in the filtering mechanism of the lymphatic system in the body. As a result, lymph fluid accumulates and causes massive swelling of limbs or tissues, a condition known as lymphedema. Worldwide prevalence of this condition, as reported by the National Institutes of Health, is around 250 million. One of the most commonly used treatment options for lymphedema is compression therapy and with increasing incidence of this condition, the demand for these therapies is set to steadily rise.

Healthy R&D Funding to Fuel the Market in North America

The market size in North America stood at USD 1.05 billion in 2018 backed by concerted investment in healthcare research and development by the private and public sectors. In addition to that, rising geriatric population and strong presence of global companies is anticipated to aid the region to dominate the compression therapy market share during the forecast period. In Europe, the primary growth propeller will be the development and launch of innovative products by players in the region. On the other hand, steadily increasing number of patients with lymphatic and venous conditions is expected to augur well for the market in Asia-Pacific.